Mosaic ImmunoEngineering Inc. financial data

Symbol
CPMV on OTC
Location
9114 Adams Ave., #202, Huntington Beach, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
PATRIOT SCIENTIFIC CORP (to 11/19/2020)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.55 % -75.2%
Debt-to-equity -101 % +3.65%
Return On Equity 17 % -28.6%
Return On Assets -1.37K % -193%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.24M shares 0%
Common Stock, Shares, Outstanding 7.24M shares 0%
Entity Public Float 817K USD -44.4%
Common Stock, Value, Issued 72 USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.24M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 7.24M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 218K USD -63.3%
General and Administrative Expense 788K USD -23.5%
Operating Income (Loss) -1.01M USD +38%
Nonoperating Income (Expense) -59.4K USD -116%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.06M USD +14.5%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -1.06M USD +14.6%
Earnings Per Share, Basic -0.14 USD/shares +22.2%
Earnings Per Share, Diluted -0.14 USD/shares +22.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.74K USD -97.7%
Assets, Current 40K USD -86%
Assets 40K USD -86%
Accounts Payable, Current 144K USD +23.4%
Employee-related Liabilities, Current 3.64M USD +21.6%
Accrued Liabilities, Current 654K USD +0.69%
Liabilities, Current 5.3M USD +16%
Liabilities 6.68M USD +13.8%
Retained Earnings (Accumulated Deficit) -8.69M USD -14%
Stockholders' Equity Attributable to Parent -6.64M USD -18.9%
Liabilities and Equity 40K USD -86%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -91.1K USD +47%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.24M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.74K USD -97.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 3.15M USD +11.5%
Deferred Tax Assets, Operating Loss Carryforwards 442K USD -12.4%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 2.05M USD +0.51%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 4.87K USD -10%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%